Pharmaceutical

Orion and Glykos extend ADC collaboration

Orion Corporation has broadened its partnership with Glykos, focusing on the development of antibody-drug conjugates (ADCs).

Jun 19, 2025 - 06:00
Orion and Glykos extend ADC collaboration
Orion Corporation has broadened its partnership with Glykos, focusing on the development of antibody-drug conjugates (ADCs).
Read the original article

Tags:

Previous Article

Novo Nordisk seeks digital health partners to boost GLP-1RA weight loss outcomes

Next Article

FDA creates new priority review voucher scheme to boost US interests

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Bluejay touts positive data for chronic hepatitis D treatment

Bluejay touts positive data for chronic hepatitis D tre...

Jun 6, 2024

Opinion: Doctors — and patients — must seek alternatives to long-term steroids

Opinion: Doctors — and patients — must seek alternative...

Oct 16, 2023

Twist and Cancer Research Horizons sign antibody library platform deal

Twist and Cancer Research Horizons sign antibody librar...

Jul 19, 2023